Nonenhancing tumors of the spinal cord

Journal of Neurosurgery: Spine

Volumn 7, Issue 4, 2007, Pages 403-407

  White, J Bradley ^a,b   Miller, Gary M ^a   Layton, Kennith F ^a   Krauss, William E ^a  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Contrast enhancement; Intramedullary lesion; Spinal cord neoplasm

Indexed keywords

CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BONE BIOPSY; CERVICAL SPINE; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; EPENDYMOMA; FEMALE; FOLLOW UP; GLIOMA; HEMANGIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PLASMACYTOMA; RETROSPECTIVE STUDY; SPINAL CORD TUMOR; SUBEPENDYMOMA; THORACOLUMBAR SPINE; TUMOR BIOPSY; TUMOR GROWTH; VERTEBRA;

EID: 35348827794     PISSN: 15475654     EISSN: None     Source Type: Journal    
DOI: 10.3171/SPI-07/09/10/403     Document Type: Conference Paper

References (14)

1. Bydder GM, Brown J, Niendorf HP, Young IR: Enhancement of cervical intraspinal tumors in MR imaging with intravenous gadolinium-DTPA. J Comput Assist Tomogr 9:847-851, 1985
2. Carr DH, Brown J, Bydder GM, Steiner RE, Weinmann HJ, Speck U, et al: Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Radiol 43:215-224, 1984
3. Castillo M: Contrast enhancement in primary tumors of the brain and spinal cord. Neuroimaging Clin N Am 4:63-80, 1994
4. Chamberlain MC, Sandy AD, Press GA: Spinal cord tumors: gadolinium-DTPA-enhanced MR imaging. Neuroradiology 33:469-474, 1991
5. Fulbright R, Ross JS, Sze G: Application of contrast agents in MR imaging of the spine. J Magn Reson Imaging 3:219-232, 1993
6. Graif M, Steiner RE: Contrast-enhanced magnetic resonance imaging of tumors of the central nervous system: a clinical review. Br J Radiol 59:865-873, 1986
7. Koeller KK, Rosenblum RS, Morrison AL: Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 20:1721-1749, 2000
8. Muroff LR, Runge VM: The use of MR contrast in neoplastic disease of the brain. Top Magn Reson Imaging 7:137-157, 1995
9. Parizel PM, Balériaux D, Rodesch G, Segebarth C, Lalmand B, Christophe C, et al: Gd-DTPA-enhanced MR imaging of spinal tumors. AJR Am J Radiol 152:1087-1096, 1989
10. Rothwell CI, Jaspan T, Worthington BS, Holland IM: Gadolinium-enhanced magnetic resonance imaging of spinal tumors. Br J Radiol 62:1067-1074, 1989
11. Runge VM, Carollo BR, Wolf CR, Nelson KL, Gelblum DY: Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging. Radiographics 9:929-958, 1989
12. Slasky BS, Bydder GM, Niendorf HP, Young IR: MR imaging with gadolinium-DTPA in the differentiation of tumor, syrinx, and cyst of the spinal cord. J Comput Assist Tomogr 11:845-850, 1987
13. Sze G: Gadolinium-DTPA in spinal disease. Radiol Clin North Am 26:1009-1024, 1988
14. Sze G, Stimac GK, Bartlett C, Dillon WP, Haughton VM, Orrison W, et al: Multicenter study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with spinal tumors. AJNR Am J Neuroradiol 11:967-974, 1990